The Relationship between Mechanical Hyperalgesia Assessed by Manual Tender Point Examination and Disease Severity in Patients with Chronic Widespread Pain: A Cross-Sectional Study
The clinical utility of tender point (TP) examination in patients reporting chronic widespread pain (CWP) is the subject of contemporary debate. The objective of this study was to assess the relationship between mechanical hyperalgesia assessed by manual TP examination and clinical disease severity. 271 women with CWP were recruited from a clinical setting. Data collection included patient-reported symptoms, health-related quality of life variables, and observation-based measures of functional ability, muscle strength, 6-minute walk, and pressure pain thresholds measured by cuff algometry. TP examination was conducted according to ACR-guidelines. Relationships between disease variables and TP count (TPC) were analyzed with logistic regression in a continuum model, allowing the TPC to depend on the included disease variables and two regression models carried out for a TPC threshold level, varying between 1 and 17. The threshold analyses indicated a TPC threshold at 8, above which a large number of disease variables became consistently significant explanatory factors, whereas none of the disease variables reached a significance level in the continuum model. These results support the premise that the presence of mechanical hyperalgesia influences symptomatology in CWP and that the severity of clinical expression is related to a threshold of TPs, rather than being part of a continuum. 1. Introduction Fibromyalgia is a characterized subgroup of patients presenting with chronic widespread pain (CWP) and widespread mechanical hyperalgesia. These characteristics are enshrined in the 1990-ACR criteria [1] that have been the cornerstone for research studies of the past 2 decades. Contemporary research in subjects fulfilling 1990-ACR criteria has provided persuasive evidence for augmented central pain processing in terms of sensitization of nociceptive neurons and ascending spinal tracts accompanied by dysfunction of descending pain inhibitory pathways [2]. The underlying pain mechanisms in subjects with CWP with fewer than 11 tender points (TP) are less well described [2]. Mechanical hyperalgesia is a clinical manifestation of central sensitization and, although an imperfect measure, the manual TP examination has been considered a primary identifier of pain hypersensitivity [3–6]. In the development of the 1990 ACR classification criteria for fibromyalgia, TPs were found to be the most powerful discriminator between fibromyalgia and control subjects; the best separation occurred at about the 13 TPs for mild tenderness (the subject state that palpation is painful)
References
[1]
F. Wolfe, H. A. Smythe, M. B. Yunus et al., “The American College of Rheumatology 1990. Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee,” Arthritis and Rheumatism, vol. 33, no. 2, pp. 160–172, 1990.
[2]
R. Staud, “Chronic widespread pain and fibromyalgia: two sides of the same coin?” Current Rheumatology Reports, vol. 11, no. 6, pp. 433–436, 2009.
[3]
G. Carli, A. L. Suman, G. Biasi, and R. Marcolongo, “Reactivity to superficial and deep stimuli in patients with chronic musculoskeletal pain,” Pain, vol. 100, no. 3, pp. 259–269, 2002.
[4]
R. H. Gracely, M. A. B. Grant, and T. Giesecke, “Evoked pain measures in fibromyalgia,” Best Practice and Research: Clinical Rheumatology, vol. 17, no. 4, pp. 593–609, 2003.
[5]
S. Lautenbacher, G. B. Rollman, and G. A. McCain, “Multi-method assessment of experimental and clinical pain in patients with fibromyalgia,” Pain, vol. 59, no. 1, pp. 45–53, 1994.
[6]
R. Staud, “Predictors of clinical pain intensity in patients with fibromyalgia syndrome,” Current Pain and Headache Reports, vol. 9, no. 5, pp. 316–321, 2005.
[7]
F. Wolfe, “The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic,” Annals of the Rheumatic Diseases, vol. 56, no. 4, pp. 268–271, 1997.
[8]
F. Wolfe, “Stop using the American College of Rheumatology criteria in the clinic,” The Journal of Rheumatology, vol. 30, no. 8, pp. 1671–1672, 2003.
[9]
F. Wolfe, D. J. Clauw, M. Fitzcharles et al., “The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity,” Arthritis Care and Research, vol. 62, no. 5, pp. 600–610, 2010.
[10]
H. S. Smith, R. Harris, and D. Clauw, “Fibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome,” Pain Physician, vol. 14, no. 2, pp. E217–E245, 2011.
[11]
M. Henriksen, H. Lund, R. Christensen et al., “Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study,” Arthritis Care and Research, vol. 61, no. 6, pp. 732–739, 2009.
[12]
J. G. McVeigh, M. B. Finch, D. A. Hurley, J. R. Basford, J. Sim, and G. D. Baxter, “Tender point count and total myalgic score in fibromyalgia: changes over a 28-day period,” Rheumatology International, vol. 27, no. 11, pp. 1011–1018, 2007.
[13]
F. Petzke, R. H. Gracely, K. M. Park, K. Ambrose, and D. J. Clauw, “What do tender points measure? Influence of distress on 4 measures of tenderness,” The Journal of Rheumatology, vol. 30, no. 3, pp. 567–574, 2003.
[14]
A. Salli, H. Yilmaz, and H. Ugurlu, “The relationship between tender point count and disease severity in patients with primary fibromyalgia,” Rheumatology International, vol. 32, no. 1, pp. 105–107, 2012.
[15]
N. Tastekin, M. Birtane, and K. Uzunca, “Which of the three different tender points assessment methods is more useful for predicting the severity of fibromyalgia syndrome?” Rheumatology International, vol. 27, no. 5, pp. 447–451, 2007.
[16]
WHO, International Classification of Functioning, Disability and Health, WHO, Geneva, Switzerland, 2001.
[17]
S. R. Schwarzkopf, T. Ewert, K. E. Dreinh?fer, A. Cieza, and G. Stucki, “Towards an ICF Core Set for chronic musculoskeletal conditions: commonalities across ICF Core Sets for osteoarthritis, rheumatoid arthritis, osteoporosis, low back pain and chronic widespread pain,” Clinical Rheumatology, vol. 27, no. 11, pp. 1355–1361, 2008.
[18]
A. Cieza, G. Stucki, M. Weigl et al., “ICF Core Sets for chronic widespread pain,” Journal of Rehabilitation Medicine, vol. 36, no. 44, supplement, pp. 63–68, 2004.
[19]
R. Hieblinger, M. Coenen, G. Stucki, A. Winkelmann, and A. Cieza, “Validation of the international classification of functioning, disability and health core set for chronic widespread pain from the perspective of fibromyalgia patients,” Arthritis Research and Therapy, vol. 11, no. 3, article R67, 2009.
[20]
R. Hieblinger, M. Coenen, G. Stucki, A. Winkelmann, and A. Cieza, “Identification of essential elements of functioning in chronic widespread pain based on a statistical approach,” American Journal of Physical Medicine and Rehabilitation, vol. 90, no. 12, pp. 979–991, 2011.
[21]
M. Offenb?cher, A. Cieza, T. Brockow, E. Amann, B. Kollerits, and G. Stucki, “Are the contents of treatment outcomes in fibromyalgia trials represented in the international classification of functioning, disability, and health?” Clinical Journal of Pain, vol. 23, no. 8, pp. 691–701, 2007.
[22]
B. Prodinger, A. Cieza, D. A. Williams et al., “Measuring health in patients with fibromyalgia: content comparison of questionnaires based on the international classification of functioning, disability and health,” Arthritis Care and Research, vol. 59, no. 5, pp. 650–658, 2008.
[23]
B. Prodinger, T. Salzberger, G. Stucki, T. Stamm, and A. Cieza, “Measuring functioning in people with fibromyalgia (FM) based on the international classification of functioning, disability and health (ICF)—a psychometric analysis,” Pain Practice, vol. 12, no. 4, pp. 255–265, 2012.
[24]
A. G. Fisher, Assessment of Motor and Process Skills: Development, Standardization, and Administration Manual, Volume 1, Three Star Press, Fort Collins, Colo, USA, 2006.
[25]
A. G. Fisher, Assessment of Motor and Process Skills: User Manual, Volume 2, Three Star Press, Fort Collins, Colo, USA, 2006.
[26]
E. E. W?hrens, K. Amris, and A. G. Fisher, “Performance-based assessment of activities of daily living (ADL) ability among women with chronic widespread pain,” Pain, vol. 150, no. 3, pp. 535–541, 2010.
[27]
G. E. Burch and L. Shewey, “Sphygmomanometric cuff size and blood pressure recordings,” Journal of the American Medical Association, vol. 225, no. 10, pp. 1215–1218, 1973.
[28]
A. Jespersen, L. Dreyer, S. Kendall et al., “Computerized cuff pressure algometry: a new method to assess deep-tissue hypersensitivity in fibromyalgia,” Pain, vol. 131, no. 1-2, pp. 57–62, 2007.
[29]
P. J. Mease, D. J. Clauw, L. M. Arnold et al., “Fibromyalgia syndrome,” The Journal of Rheumatology, vol. 32, no. 11, pp. 2270–2277, 2005.
[30]
P. J. Mease, L. M. Arnold, R. Bennett et al., “Fibromyalgia syndrome,” The Journal of Rheumatology, vol. 34, no. 6, pp. 1415–1425, 2007.
[31]
D. C. Turk, R. H. Dworkin, R. R. Allen et al., “Core outcome domains for chronic pain clinical trials: IMMPACT recommendations,” Pain, vol. 106, no. 3, pp. 337–345, 2003.
[32]
K. Amris, E. E. W?hrens, A. Jespersen, H. Bliddal, and B. Danneskiold-Sams?e, “Observation-based assessment of functional ability in patients with chronic widespread pain: a cross-sectional study,” Pain, vol. 152, no. 11, pp. 2470–2476, 2011.
[33]
K. Mannerkorpi, U. Svantesson, and C. Broberg, “Relationships between performance-based tests and patients' ratings of activity limitations, self-efficacy, and pain in fibromyalgia,” Archives of Physical Medicine and Rehabilitation, vol. 87, no. 2, pp. 259–264, 2006.
[34]
J. L. Poole, G. Atanasoff, J. C. Pelsor, and W. L. Sibbitt Jr., “Comparison of a self-report and performance-based test of disability in people with systemic lupus erythematosus,” Disability and Rehabilitation, vol. 28, no. 10, pp. 653–658, 2006.
[35]
R. A. Moore, S. Straube, J. Paine, C. J. Phillips, S. Derry, and H. J. McQuay, “Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain,” Pain, vol. 149, no. 2, pp. 360–364, 2010.
[36]
K. Avlund, M. T. Damsgaard, R. Sakari-Rantala, P. Laukkanen, and M. Schroll, “Tiredness in daily activities among nondisabled old people as determinant of onset of disability,” Journal of Clinical Epidemiology, vol. 55, no. 10, pp. 965–973, 2002.
[37]
M. Martínez-Lavin, S. López, M. Medina, and A. Nava, “Use of the leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia,” Seminars in Arthritis and Rheumatism, vol. 32, no. 6, pp. 407–411, 2003.
[38]
?. N. Pamuk, Y. Yethil, and N. ?akir, “Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR, 1990 criteria for fibromyalgia: are tender points a reflection of neuropathic pain?” Seminars in Arthritis and Rheumatism, vol. 36, no. 2, pp. 130–134, 2006.
[39]
S. Perrot, D. Bouhassira, and J. Fermanian, “Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST),” Pain, vol. 150, no. 2, pp. 250–256, 2010.
[40]
K. Amris, A. Jespersen, and H. Bliddal, “Self-reported somatosensory symptoms of neuropathic pain in fibromyalgia and chronic widespread pain correlate with tender point count and pressure-pain thresholds,” Pain, vol. 151, no. 3, pp. 664–669, 2010.
[41]
K. Thieme, C. Spies, P. Sinha, D. C. Turk, and H. Flor, “Predictors of pain behaviors in fibromyalgia syndrome,” Arthritis Care and Research, vol. 53, no. 3, pp. 343–350, 2005.
[42]
D. C. Turk, A. Okifuji, J. David Sinclair, and T. W. Starz, “Pain, disability, and physical functioning in subgroups of patients with fibromyalgia,” The Journal of Rheumatology, vol. 23, no. 7, pp. 1255–1262, 1996.
[43]
L. C?ster, S. Kendall, B. Gerdle, C. Henriksson, K. G. Henriksson, and A. Bengtsson, “Chronic widespread musculoskeletal pain—a comparison of those who meet criteria for fibromyalgia and those who do not,” European Journal of Pain, vol. 12, no. 5, pp. 600–610, 2008.
[44]
H. Breivik, B. Collett, V. Ventafridda, R. Cohen, and D. Gallacher, “Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment,” European Journal of Pain, vol. 10, no. 4, pp. 287–333, 2006.